Safety of RC017 eye ointment in healthy adults
Part of Eyes & vision clinical trials.
This study tests an eye ointment (RC017) in healthy adults to check its safety and how the body processes it. It may help doctors understand if this treatment for eye conditions is safe before it's used in patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old.
- Your body mass index (BMI) should be between 19 and 26, and you must weigh at least 50 kg (men) or 45 kg (women).
- You need to have normal or corrected vision (at least 20/20) and healthy eyes with no eye disease or previous eye surgery.
- You cannot have used any prescription or over-the-counter medications (including vitamins or eye drops) within 2 weeks before the study.
- You must be a non-smoker (or smoke less than 5 cigarettes a day) and not have a history of alcohol or drug abuse.
- You must not have participated in another clinical trial or donated blood within the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental eye drop for people with dry eye disease. It aims to see if the drops can reduce symptoms and signs of dry eye.
This study tests an investigational eye drop called OT202 to see if it helps people with moderate to severe dry eye. If you join, you'll receive either the study drug or a placebo (no active ingredient) and have your symptoms and eye health monitored for several months.
This trial tests whether a new eye drop, JN002, can help people with dry eye disease. It checks if the drops improve symptoms and eye health over time.
This study tests a new eye drop called PRO-190 to see if it's safe and comfortable for the eyes, comparing it to a common artificial tear (Systane Ultra). It is for healthy people and may help if you have dry or irritated eyes.
This trial tests whether a new eye drop called BT01001 is safe for healthy adults. You may join if you have good overall and eye health, and do not use contact lenses or have chronic eye problems.
This phase 1 trial tests the safety of an investigational eye drop called IVMED-85 in healthy adults aged 18-49. Participants will receive the eye drops and be monitored for any side effects over 6 weeks.
Hear when a new Dry Eye trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.